Journey Medical Corp Deferred Income Tax Expense (Benefit)
Journey Medical Corp (DERM) reported Deferred Income Tax Expense (Benefit) of $1.57 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2023-03-31
- Journey Medical Corp deferred income tax expense (benefit) for the quarter ending 2021-12-31 was $8.27M.
- Journey Medical Corp deferred income tax expense (benefit) for the quarter ending 2021-09-30 was -$3.29M.
- Journey Medical Corp deferred income tax expense (benefit) for the quarter ending 2021-06-30 was -$3.48M.
- Journey Medical Corp deferred income tax expense (benefit) for the quarter ending 2021-03-31 was $69.00K.
- Journey Medical Corp deferred income tax expense (benefit) for fiscal 2021 was $1.57M.
- Journey Medical Corp deferred income tax expense (benefit) for fiscal 2020 was -$335.00K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2021-12-31 | $8.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $4.98M derived: sum of 2 quarters · filed 2023-03-31 | $1.50M derived: sum of 3 quarters · filed 2023-03-31 | $1.57M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$3.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$6.77M derived: sum of 2 quarters · filed 2022-11-10 | -$6.70M 10-Q · filed 2022-11-10 | -$7.08M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$3.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$3.41M 10-Q · filed 2022-08-09 | -$3.79M derived: sum of 3 quarters · filed 2022-08-09 | |
| 2021-03-31 | $69.00K 10-Q · filed 2022-05-10 | -$310.00K derived: sum of 2 quarters · filed 2022-05-10 | ||
| 2020-12-31 | -$379.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$335.00K 10-K · filed 2022-03-28 | ||
| 2020-09-30 | $44.00K 10-Q · filed 2021-12-16 |